NCT04410302View on ClinicalTrials.gov

Patient-Derived Xenografts to Reduce Cancer Health Disparities

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Bladder CarcinomaGastric CarcinomaLiver and Intrahepatic Bile Duct CarcinomaLung CarcinomaMalignant Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of tumor tissue, blood, saliva, and urine samples

Trial Locations (2)

92868

RECRUITING

UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

95817

RECRUITING

University of California Davis Comprehensive Cancer Center, Sacramento

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, Davis

OTHER